Global Antimicrobial Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
The Antimicrobial Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Antimicrobial Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Antimicrobial Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Antimicrobial Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hospital
Clinic
Personal
Other
Market segment by Application, can be divided into
Antiviral
Antibacterial
Antifungal
Antiparasitic
Market segment by players, this report covers
Gilead Sciences, Inc.
GlaxoSmithKline plc
Merck & Co Inc.
Pfizer Inc.
Sanofi
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Antimicrobial Therapeutics
1.2 Classification of Antimicrobial Therapeutics by Type
1.2.1 Overview: Global Antimicrobial Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Antimicrobial Therapeutics Revenue Market Share by Type in 2020
1.2.3 Hospital
1.2.4 Clinic
1.2.5 Personal
1.2.6 Other
1.3 Global Antimicrobial Therapeutics Market by Application
1.3.1 Overview: Global Antimicrobial Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Antiviral
1.3.3 Antibacterial
1.3.4 Antifungal
1.3.5 Antiparasitic
1.4 Global Antimicrobial Therapeutics Market Size & Forecast
1.5 Global Antimicrobial Therapeutics Market Size and Forecast by Region
1.5.1 Global Antimicrobial Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Antimicrobial Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Antimicrobial Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Antimicrobial Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Antimicrobial Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Antimicrobial Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Antimicrobial Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Antimicrobial Therapeutics Market Drivers
1.6.2 Antimicrobial Therapeutics Market Restraints
1.6.3 Antimicrobial Therapeutics Trends Analysis
2 Company Profiles
2.1 Gilead Sciences, Inc.
2.1.1 Gilead Sciences, Inc. Details
2.1.2 Gilead Sciences, Inc. Major Business
2.1.3 Gilead Sciences, Inc. Antimicrobial Therapeutics Product and Solutions
2.1.4 Gilead Sciences, Inc. Antimicrobial Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Gilead Sciences, Inc. Recent Developments and Future Plans
2.2 GlaxoSmithKline plc
2.2.1 GlaxoSmithKline plc Details
2.2.2 GlaxoSmithKline plc Major Business
2.2.3 GlaxoSmithKline plc Antimicrobial Therapeutics Product and Solutions
2.2.4 GlaxoSmithKline plc Antimicrobial Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 GlaxoSmithKline plc Recent Developments and Future Plans
2.3 Merck & Co Inc.
2.3.1 Merck & Co Inc. Details
2.3.2 Merck & Co Inc. Major Business
2.3.3 Merck & Co Inc. Antimicrobial Therapeutics Product and Solutions
2.3.4 Merck & Co Inc. Antimicrobial Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck & Co Inc. Recent Developments and Future Plans
2.4 Pfizer Inc.
2.4.1 Pfizer Inc. Details
2.4.2 Pfizer Inc. Major Business
2.4.3 Pfizer Inc. Antimicrobial Therapeutics Product and Solutions
2.4.4 Pfizer Inc. Antimicrobial Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Inc. Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Antimicrobial Therapeutics Product and Solutions
2.5.4 Sanofi Antimicrobial Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sanofi Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Antimicrobial Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Antimicrobial Therapeutics Players Market Share
3.2.2 Top 10 Antimicrobial Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Antimicrobial Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Antimicrobial Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Antimicrobial Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Antimicrobial Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Antimicrobial Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Antimicrobial Therapeutics Revenue by Type (2016-2026)
6.2 North America Antimicrobial Therapeutics Revenue by Application (2016-2026)
6.3 North America Antimicrobial Therapeutics Market Size by Country
6.3.1 North America Antimicrobial Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Antimicrobial Therapeutics Revenue by Type (2016-2026)
7.2 Europe Antimicrobial Therapeutics Revenue by Application (2016-2026)
7.3 Europe Antimicrobial Therapeutics Market Size by Country
7.3.1 Europe Antimicrobial Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Antimicrobial Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Antimicrobial Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Antimicrobial Therapeutics Market Size by Region
8.3.1 Asia-Pacific Antimicrobial Therapeutics Revenue by Region (2016-2026)
8.3.2 China Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Antimicrobial Therapeutics Revenue by Type (2016-2026)
9.2 South America Antimicrobial Therapeutics Revenue by Application (2016-2026)
9.3 South America Antimicrobial Therapeutics Market Size by Country
9.3.1 South America Antimicrobial Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Antimicrobial Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Antimicrobial Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Antimicrobial Therapeutics Market Size by Country
10.3.1 Middle East & Africa Antimicrobial Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Antimicrobial Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Antimicrobial Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Antimicrobial Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Antimicrobial Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Antimicrobial Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Antimicrobial Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Gilead Sciences, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Gilead Sciences, Inc. Major Business
Table 8. Gilead Sciences, Inc. Antimicrobial Therapeutics Product and Solutions
Table 9. Gilead Sciences, Inc. Antimicrobial Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. GlaxoSmithKline plc Corporate Information, Head Office, and Major Competitors
Table 11. GlaxoSmithKline plc Major Business
Table 12. GlaxoSmithKline plc Antimicrobial Therapeutics Product and Solutions
Table 13. GlaxoSmithKline plc Antimicrobial Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Merck & Co Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Merck & Co Inc. Major Business
Table 16. Merck & Co Inc. Antimicrobial Therapeutics Product and Solutions
Table 17. Merck & Co Inc. Antimicrobial Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Inc. Major Business
Table 20. Pfizer Inc. Antimicrobial Therapeutics Product and Solutions
Table 21. Pfizer Inc. Antimicrobial Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sanofi Corporate Information, Head Office, and Major Competitors
Table 23. Sanofi Major Business
Table 24. Sanofi Antimicrobial Therapeutics Product and Solutions
Table 25. Sanofi Antimicrobial Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Antimicrobial Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 27. Global Antimicrobial Therapeutics Revenue Share by Players (2019-2021)
Table 28. Breakdown of Antimicrobial Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Antimicrobial Therapeutics Players Head Office, Products and Services Provided
Table 30. Antimicrobial Therapeutics Mergers & Acquisitions in the Past Five Years
Table 31. Antimicrobial Therapeutics New Entrants and Expansion Plans
Table 32. Global Antimicrobial Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 33. Global Antimicrobial Therapeutics Revenue Share by Type (2016-2021)
Table 34. Global Antimicrobial Therapeutics Revenue Forecast by Type (2021-2026)
Table 35. Global Antimicrobial Therapeutics Revenue by Application (2016-2021)
Table 36. Global Antimicrobial Therapeutics Revenue Forecast by Application (2021-2026)
Table 37. North America Antimicrobial Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Antimicrobial Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Antimicrobial Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Antimicrobial Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Antimicrobial Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Antimicrobial Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Antimicrobial Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Antimicrobial Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Antimicrobial Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Antimicrobial Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Antimicrobial Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Antimicrobial Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Antimicrobial Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Antimicrobial Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Antimicrobial Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Antimicrobial Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Antimicrobial Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Antimicrobial Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Antimicrobial Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Antimicrobial Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Antimicrobial Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Antimicrobial Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Antimicrobial Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Antimicrobial Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Antimicrobial Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Antimicrobial Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Antimicrobial Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Antimicrobial Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Antimicrobial Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Antimicrobial Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Antimicrobial Therapeutics Picture
Figure 2. Global Antimicrobial Therapeutics Revenue Market Share by Type in 2020
Figure 3. Hospital
Figure 4. Clinic
Figure 5. Personal
Figure 6. Other
Figure 7. Antimicrobial Therapeutics Revenue Market Share by Application in 2020
Figure 8. Antiviral Picture
Figure 9. Antibacterial Picture
Figure 10. Antifungal Picture
Figure 11. Antiparasitic Picture
Figure 12. Global Antimicrobial Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Antimicrobial Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Antimicrobial Therapeutics Revenue Market Share by Region (2016-2026)
Figure 15. Global Antimicrobial Therapeutics Revenue Market Share by Region in 2020
Figure 16. North America Antimicrobial Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Antimicrobial Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Antimicrobial Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Antimicrobial Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Antimicrobial Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Antimicrobial Therapeutics Market Drivers
Figure 22. Antimicrobial Therapeutics Market Restraints
Figure 23. Antimicrobial Therapeutics Market Trends
Figure 24. Gilead Sciences, Inc. Recent Developments and Future Plans
Figure 25. GlaxoSmithKline plc Recent Developments and Future Plans
Figure 26. Merck & Co Inc. Recent Developments and Future Plans
Figure 27. Pfizer Inc. Recent Developments and Future Plans
Figure 28. Sanofi Recent Developments and Future Plans
Figure 29. Global Antimicrobial Therapeutics Revenue Share by Players in 2020
Figure 30. Antimicrobial Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Antimicrobial Therapeutics Revenue Market Share in 2020
Figure 32. Global Top 10 Players Antimicrobial Therapeutics Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Antimicrobial Therapeutics Revenue Share by Type in 2020
Figure 35. Global Antimicrobial Therapeutics Market Share Forecast by Type (2021-2026)
Figure 36. Global Antimicrobial Therapeutics Revenue Share by Application in 2020
Figure 37. Global Antimicrobial Therapeutics Market Share Forecast by Application (2021-2026)
Figure 38. North America Antimicrobial Therapeutics Sales Market Share by Type (2016-2026)
Figure 39. North America Antimicrobial Therapeutics Sales Market Share by Application (2016-2026)
Figure 40. North America Antimicrobial Therapeutics Revenue Market Share by Country (2016-2026)
Figure 41. United States Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Antimicrobial Therapeutics Sales Market Share by Type (2016-2026)
Figure 45. Europe Antimicrobial Therapeutics Sales Market Share by Application (2016-2026)
Figure 46. Europe Antimicrobial Therapeutics Revenue Market Share by Country (2016-2026)
Figure 47. Germany Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Antimicrobial Therapeutics Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Antimicrobial Therapeutics Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Antimicrobial Therapeutics Revenue Market Share by Region (2016-2026)
Figure 55. China Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Antimicrobial Therapeutics Sales Market Share by Type (2016-2026)
Figure 62. South America Antimicrobial Therapeutics Sales Market Share by Application (2016-2026)
Figure 63. South America Antimicrobial Therapeutics Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Antimicrobial Therapeutics Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Antimicrobial Therapeutics Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Antimicrobial Therapeutics Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Antimicrobial Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
